ID: ALA4216851

Max Phase: Preclinical

Molecular Formula: C29H34N4O2

Molecular Weight: 470.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1CN(C)[C@H]2Cc3c([nH]c4ccccc34)/C(=N/N=C\c3ccc(C)cc3)C[C@H]1[C@H]2C(=O)OC

Standard InChI:  InChI=1S/C29H34N4O2/c1-5-20-17-33(3)26-15-23-21-8-6-7-9-24(21)31-28(23)25(14-22(20)27(26)29(34)35-4)32-30-16-19-12-10-18(2)11-13-19/h6-13,16,20,22,26-27,31H,5,14-15,17H2,1-4H3/b30-16-,32-25+/t20-,22+,26-,27+/m0/s1

Standard InChI Key:  OMPNCXXBSRGTSD-UTFKEPFESA-N

Associated Targets(Human)

Multidrug resistance-associated protein 1 2587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ATP-binding cassette sub-family G member 2 4927 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BHK-21 725 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 470.62Molecular Weight (Monoisotopic): 470.2682AlogP: 4.99#Rotatable Bonds: 4
Polar Surface Area: 70.05Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.57CX Basic pKa: 8.46CX LogP: 4.93CX LogD: 3.83
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.33Np Likeness Score: 0.37

References

1. Paterna A, Khonkarn R, Mulhovo S, Moreno A, Madeira Girio P, Baubichon-Cortay H, Falson P, Ferreira MU..  (2018)  Monoterpene indole alkaloid azine derivatives as MDR reversal agents.,  26  (2): [PMID:29233614] [10.1016/j.bmc.2017.11.052]

Source